SRL
IPSC icon

Scientech Research LLC’s Century Therapeutics IPSC Stock Holding History

Scientech Research LLC’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,355
Closed -$12.3K – 605
2025
Q4 		$12.3K Buy
+12,355
New +$7.54K 0.01% 472

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Scientech Research LLC's IPSC Position: Q1 2026 in Review

Scientech Research LLC sold out of Century Therapeutics (IPSC) in Q1 2026, closing a stake of 12,355 shares — an estimated $12.3K sold.

Scientech Research LLC first reported a position in IPSC in Q4 2025 and held it in 1 quarter. The position peaked at $12.3K in Q4 2025. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Scientech Research LLC reported no remaining Century Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Scientech Research LLC sold 12,355 Century Therapeutics shares in Q1 2026, an estimated $12.3K.
  • Scientech Research LLC first reported a position in Century Therapeutics in Q4 2025 and held it in 1 quarter.
  • Scientech Research LLC's Century Therapeutics position peaked at $12.3K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.